# INCRELEX
> **BLA021839** · Biologics License Application · Sponsor: IPSEN INC · Approved 2005-08-30
## Drug
- **FDA Application Number:** BLA021839
- **Application type:** Biologics License Application
- **Brand name:** INCRELEX
- **Generic name:** MECASERMIN
- **Active ingredients:** MECASERMIN RECOMBINANT
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** IPSEN INC
- **Manufacturer:** Ipsen Biopharmaceuticals, Inc.
- **First approval:** 2005-08-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021839)
---
*MORVS · CC0 1.0*